PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
14684685-0	2003	Somatic instability of the DNA sequences encoding the polymorphic polyglutamine tract of the AIB1 gene.	polyglutamine	66-79	ANIB1	Homo sapiens	93-97	
25263716-2	2015	AIB1 gene (amplified in breast cancer-1), an androgen receptor (AR) coactivator, expresses a polyglutamine (poly-Q) sequence within the carboxyl-terminal coding region.	polyglutamine	93-106	ANIB1	Homo sapiens	0-4	
25263716-2	2015	AIB1 gene (amplified in breast cancer-1), an androgen receptor (AR) coactivator, expresses a polyglutamine (poly-Q) sequence within the carboxyl-terminal coding region.	polyglutamine	108-114	ANIB1	Homo sapiens	0-4	
16670003-1	2006	BACKGROUND: The poly Q polymorphism in AIB1 (amplified in breast cancer) gene is usually assessed by fragment length analysis which does not reveal the actual sequence variation.	polyglutamine	16-22	ANIB1	Homo sapiens	39-43	
16670003-3	2006	METHODS: The polymorphic poly Q encoding region of AIB1 gene was investigated at the single molecule level by PCR cloning/sequencing.	polyglutamine	25-31	ANIB1	Homo sapiens	51-55	
16670003-12	2006	CONCLUSION: These data suggest that poly Q encoding region of AIB1 gene is somatic unstable in breast cancer cell lines.	polyglutamine	36-42	ANIB1	Homo sapiens	62-66	
14648706-0	2004	Polyglutamine repeat length in the AIB1 gene modifies breast cancer susceptibility in BRCA1 carriers.	polyglutamine	0-13	ANIB1	Homo sapiens	35-39	
14648706-6	2004	Three hundred eleven BRCA1/2 mutation carriers (257 were of Ashkenazi origin) were genotyped for the AIB1 polyglutamine repeat.	polyglutamine	106-119	ANIB1	Homo sapiens	101-105	
14648706-11	2004	These results indicate significant association of the risk for BC in carriers of BRCA1 mutations with the polyglutamine chain of the AIB1 gene.	polyglutamine	106-119	ANIB1	Homo sapiens	133-137	
17234271-3	2007	We have implemented efficient, cost-effective and rapid method for analysis of the AIB1 polyglutamine repeat polymorphism based on DHPLC analysis (WAVE system) of unlabeled PCR products.	polyglutamine	88-101	ANIB1	Homo sapiens	83-87	
15900600-0	2005	Breast cancer risk in BRCA1 and BRCA2 mutation carriers and polyglutamine repeat length in the AIB1 gene.	polyglutamine	60-73	ANIB1	Homo sapiens	95-99	
14684685-10	2003	A missense mutation and a very short glutamine repeat in primary tumours suggests that AIB1 activity may be modulated through poly Q, which in turn plays a role in the cotransactivation of gene expressions in breast cancers.	polyglutamine	126-132	ANIB1	Homo sapiens	87-91	
11454686-5	2001	We found that these women were at significantly higher breast cancer risk if they carried alleles with at least 28 or 29 polyglutamine repeats at AIB1, compared with women who carried alleles with fewer polyglutamine repeats [odds ratio (OR), 1.59; 95% confidence interval (CI), 1.03-2.47 and OR, 2.85; 95% CI, 1.64-4.96, respectively].	polyglutamine	121-134	ANIB1	Homo sapiens	146-150